SRETTState Real Estate Transfer Taxes
References in periodicals archive ?
Teijin Pharma Limited Opening a new window, the core company of the Teijin Groups healthcare business, and SRETT, a French IoT provider, announced today they have agreed to an exclusive distribution arrangement in Japan for TeleOx, a device developed by SRETT which remotely monitors patients respiratory functionsin oxygen therapy.
Teijin Pharma acquired the exclusive distribution rights of TeleOx in Japan from SRETT with the aim of solving existing problems and promoting more appropriate use of home oxygen therapy by introducing TeleOx which can detect the situation of oxygen inhalation at home.
By developing next-generation services for home oxygen therapy, SRETT and Teijin Pharma look forward to contributing to improved home care in Japan.